Validating and Quantifying the Patient Journey for PsO Patients Using Claims Data

The Challenge

A leading pharmaceutical client in the Immunology space sought to validate their patient journey map, derived from primary market research (PMR), using claims data for three different PsO indications. They needed a quantifiable view of the patient journey to better understand market opportunities.

ProcDNA's Solution

Collating Market Research Findings

Integrated insights from PMR to create a patient journey map, covering diagnosis, treatment lines, and market dynamics.

Identifying Key Questions to Verify

Focused on key aspects of the patient journey, including treatment stages and market positioning, to ensure the insights were aligned with the real-world data.

Creating a Stable Patient Cohort

Defined a stable cohort using claims data, aligning it with relevant business rules and criteria for accurate longitudinal analysis.

Quantifying the Patient Journey Using Claims Data

Implemented treatment lines (LOT) and analyzed patient progress from diagnosis (Dx) to treatment (Rx), uncovering insights into drug switches and treatment outcomes.

Impact

Quantified Patient Journey Map

Developed a concise and actionable patient journey map addressing key business questions (KBQs).

Treatment Line Opportunities

Identified patient opportunities across treatment lines, including drug switches.

First-Line Insight

Discovered an unmet need in the first-line (1L) treatment for patients reliant on long-term steroid use, highlighting the demand for a sustainable, user-friendly therapy.